Back to trial detailsIntake questionnaire
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Applying to Memorial Cancer Institute at Memorial Healthcare Systems (site 132) · Pembroke Pines, Florida
Answer a few short questions to share with the research team.
0 of 3 answered